期刊
AGING CLINICAL AND EXPERIMENTAL RESEARCH
卷 30, 期 1, 页码 93-95出版社
SPRINGER
DOI: 10.1007/s40520-017-0752-5
关键词
Dabigatran; Ibrutinib; Cerebral hemorrhage; Idarucizumab